Legal Challenges to the FDA Approval of Medication Abortion Pills March 13, 2023 Issue Brief This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA’s approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.
KFF Examines the Hyde Amendment and its Impact in States Without Abortion Bans March 14, 2024 News Release KFF takes a new look at the continued impact of the Hyde Amendment, the federal ban on payment for abortion services, in the wake of the Supreme Court’s Dobbs decision. At a moment when all eyes are on states that have banned abortion, the Hyde Amendment remains a barrier to…
Over-the-Counter Oral Contraceptive Pills September 14, 2023 Issue Brief Oral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.
The Availability and Use of Medication Abortion March 20, 2024 Fact Sheet This factsheet provides an overview of medication abortion, with a focus on federal and state regulations pertaining to its provision and coverage, and the role of the drug in self-managed abortions.
The Supreme Court, Medication Abortion, and the FDA: What’s at Stake? March 22, 2024 News Release In advance of oral arguments about access to medication abortion before the Supreme Court on March 26, KFF examines how a Court ruling for the plaintiffs would limit access to mifepristone blocking its use in telehealth and distribution through pharmacies, including in states where abortion is legal and protected. In…
The Right to Contraception: State and Federal Actions, Misinformation, and the Courts October 26, 2023 Issue Brief This issue brief explains how misinformation about contraceptives and how pregnancy is defined in state abortion bans may impact contraceptive access, and outlines the legal protections some states have established to affirm the right to obtain contraceptives.
Variability in Payment Rates for Abortion Services Under Medicaid March 28, 2024 Issue Brief This brief looks at Medicaid reimbursement rates for abortion services across states, including D&C and D&E procedures, and medication abortion. There is tremendous variability in how much states reimburse for abortion services.
What’s at Stake for Access to Medication Abortion and the FDA in the Supreme Court Case FDA v. the Alliance for Hippocratic Medicine? March 21, 2024 Issue Brief The Supreme Court will be hearing oral arguments for the case FDA v. Alliance for Hippocratic Medicine. This brief explains the issues at stake before the court and their implications for the drug regulatory process and medication abortion access throughout the country.
KFF Health Tracking Poll March 2024: Abortion in the 2024 Election and Beyond March 7, 2024 Poll Finding This poll finds 1 in 8 voters say abortion is the most important issue to their vote. They are younger, lean Democratic, and generally want abortion to be legal in all or most cases. The poll also gauges the public’s views on abortion-related policies, including a national 16-week abortion ban and allowing abortion for pregnancy-related emergencies.